Company Page

Third Rock Ventures is a leading healthcare venture capital firm focused on disruptive areas of science and medicine to discover, launch, and build transformational life science companies. The firm invests in biotechnology startups with high growth potential across cancer, rare genetic disorders, immune disorders, and other areas of unmet medical need. Third Rock has invested in more than 70 companies and has seen 19 IPOs and 23 acquisitions in its portfolio, including Blueprint Medicines, Foundation Medicine, and Thrive Earlier Detection.

Company Founded in 2007

Healthtech & Biotech